Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy

Juan Carlos Nunez-Enriquez,Rubi Romo-Rodriguez, Pedro Gaspar-Mendoza,Gabriela Zamora-Herrera, Lizeth Torres-Pineda, Jiovanni Amador-Cardoso, Jebea A. Lopez-Blanco, Laura Alfaro-Hernandez, Lucero Lopez-Garcia, Arely Rosas-Cruz, Dulce Rosario Alberto-Aguilar, Cesar Omar Trejo-Pichardo,Dalia Ramirez-Ramirez, Astin Cruz-Maza,Janet Flores-Lujano, Nuria Luna-Silva, Angelica Martinez-Martell, Karina Martinez-Jose, Anabel Ramirez-Ramirez,Juan Carlos Solis-Poblano, Patricia Zagoya-Martinez,Vanessa Teran-Cerqueda, Andrea Huerta-Moreno, Alvaro Montiel-Jarquin, Miguel Garrido-Hernandez, Raquel Hernandez-Ramos, Daniela Olvera-Caraza, Cynthia Shanat Cruz-Medina, Enoch Alvarez-Rodriguez,Lenica Anahi Chavez-Aguilar, Wilfrido Herrera-Olivares, Brianda Garcia-Hidalgo, Lena Sarahi Cano-Cuapio, Claudia Guevara-Espejel,Gerardo Juarez-Avendano,Juan Carlos Balandran, Ma. del Rocio Banos-Lara, Mariana Cardenas-Gonzalez, Elena R. Alvarez-Buylla, Sonia Mayra Perez-Tapia, Diana Casique-Aguirre,Rosana Pelayo

FRONTIERS IN ONCOLOGY(2024)

引用 0|浏览2
暂无评分
摘要
The main objective of the National Project for Research and Incidence of Childhood Leukemias is to reduce early mortality rates for these neoplasms in the vulnerable regions of Mexico. This project was conducted in the states of Oaxaca, Puebla, and Tlaxcala. A key strategy of the project is the implementation of an effective roadmap to ensure that leukemia patients are the target of maximum benefit of interdisciplinary collaboration between researchers, clinicians, surveyors, and laboratories. This strategy guarantees the comprehensive management of diagnosis and follow-up samples of pediatric patients with leukemia, centralizing, managing, and analyzing the information collected. Additionally, it allows for a precise diagnosis and monitoring of the disease through immunophenotype and measurable residual disease (MRD) studies, enhancing research and supporting informed clinical decisions for the first time in these regions through a population-based study. This initiative has significantly improved the diagnostic capacity of leukemia in girls, boys, and adolescents in the regions of Oaxaca, Puebla, and Tlaxcala, providing comprehensive, high-quality care with full coverage in the region. Likewise, it has strengthened collaboration between health institutions, researchers, and professionals in the sector, which contributes to reducing the impact of the disease on the community.
更多
查看译文
关键词
childhood leukemias,Mexico,measurable residual disease (MRD),diagnosis,vulnerable regions
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要